| Product Code: ETC7264553 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Gambia insulin drugs & devices market experienced a significant decline in imports from 2020 to 2024, with a compound annual growth rate (CAGR) of -21.06%. The year-on-year growth rate further decreased to -47.77% in 2024, reflecting a continuous downward trend in import volumes during this period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gambia Insulin Drugs & Devices Market Overview |
3.1 Gambia Country Macro Economic Indicators |
3.2 Gambia Insulin Drugs & Devices Market Revenues & Volume, 2022 & 2032F |
3.3 Gambia Insulin Drugs & Devices Market - Industry Life Cycle |
3.4 Gambia Insulin Drugs & Devices Market - Porter's Five Forces |
3.5 Gambia Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Drugs, 2022 & 2032F |
3.6 Gambia Insulin Drugs & Devices Market Revenues & Volume Share, By Combination drugs, 2022 & 2032F |
3.7 Gambia Insulin Drugs & Devices Market Revenues & Volume Share, By Non-Insulin Injectable drugs, 2022 & 2032F |
3.8 Gambia Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Device, 2022 & 2032F |
4 Gambia Insulin Drugs & Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Gambia Insulin Drugs & Devices Market Trends |
6 Gambia Insulin Drugs & Devices Market, By Types |
6.1 Gambia Insulin Drugs & Devices Market, By Insulin Drugs |
6.1.1 Overview and Analysis |
6.1.2 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Drugs, 2022-2032F |
6.1.3 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Basal or Long Acting Insulins, 2022-2032F |
6.1.4 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Bolus or Fast Acting Insulins, 2022-2032F |
6.1.5 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Traditional Human Insulins, 2022-2032F |
6.1.6 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Biosimilar Insulins, 2022-2032F |
6.2 Gambia Insulin Drugs & Devices Market, By Combination drugs |
6.2.1 Overview and Analysis |
6.2.2 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Insulin combinations, 2022-2032F |
6.2.3 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Oral Combinations, 2022-2032F |
6.3 Gambia Insulin Drugs & Devices Market, By Non-Insulin Injectable drugs |
6.3.1 Overview and Analysis |
6.3.2 Gambia Insulin Drugs & Devices Market Revenues & Volume, By GLP-1 receptor agonists, 2022-2032F |
6.3.3 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Amylin Analogue, 2022-2032F |
6.4 Gambia Insulin Drugs & Devices Market, By Insulin Device |
6.4.1 Overview and Analysis |
6.4.2 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pumps, 2022-2032F |
6.4.3 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pens, 2022-2032F |
6.4.4 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Syringes, 2022-2032F |
6.4.5 Gambia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Jet Injectors, 2022-2032F |
7 Gambia Insulin Drugs & Devices Market Import-Export Trade Statistics |
7.1 Gambia Insulin Drugs & Devices Market Export to Major Countries |
7.2 Gambia Insulin Drugs & Devices Market Imports from Major Countries |
8 Gambia Insulin Drugs & Devices Market Key Performance Indicators |
9 Gambia Insulin Drugs & Devices Market - Opportunity Assessment |
9.1 Gambia Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Drugs, 2022 & 2032F |
9.2 Gambia Insulin Drugs & Devices Market Opportunity Assessment, By Combination drugs, 2022 & 2032F |
9.3 Gambia Insulin Drugs & Devices Market Opportunity Assessment, By Non-Insulin Injectable drugs, 2022 & 2032F |
9.4 Gambia Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Device, 2022 & 2032F |
10 Gambia Insulin Drugs & Devices Market - Competitive Landscape |
10.1 Gambia Insulin Drugs & Devices Market Revenue Share, By Companies, 2025 |
10.2 Gambia Insulin Drugs & Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here